Qutenza (capsaicin)
- Region
- 🇪🇺 EU
- Active substance
- capsaicin
- Company
- Grunenthal GmbH
- Status
- Authorised
- Therapeutic area
- Neuralgia
- CHMP opinion
- Thu 19 Mar 2009
- EU approval
- Fri 15 May 2009
- Application
- EMEA/H/C/000909
- ATC
- N01BX04
- Official record
- www.ema.europa.eu
Indication
Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for pain.
Regulatory milestones
No milestones recorded in the last year.
Follow Qutenza
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.